Audit Readiness for EMA Biologics Inspections

digi — Mon, 09 Jun 2025 11:36:37 +0000

Audit Readiness for EMA Biologics Inspections Ensuring Audit Readiness for EMA Biologics Inspections Biologics manufacturing—ranging from monoclonal antibodies to vaccines and advanced therapy medicinal products (ATMPs)—is governed by some of the most stringent Good Manufacturing Practice (GMP) expectations in the pharmaceutical industry. European regulators, including the European Medicines Agency (EMA), conduct specialized GMP inspections of...

biologics QA readiness EU – Pharma GMP

Audit Readiness for EMA Biologics Inspections